The fighting in Iraq has prompted a 4% jump in Brent crude prices to a nine-month high around $113 a barrel, as fears over a hit to Iraqi oil production have grown.
This week, militants from the Islamic State of Iraq and the Levant (Isis) were fighting government forces for control of northern Iraq's key oil facility, after making rapid gains across central Iraq in recent weeks. Iraq currently exports approximately 2.5 million barrels per day (mbpd). It is expected to be able to boost production to 4.3mbpd by 2018.
What the commentators said
What's more, added Morgan Stanley, the south is a Shia stronghold that is better fortified. Iran is also going to send reinforcements. Still, while the premium on near-term oil futures should now fade, long-dated oil is likely to remain elevated.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
The worry is that Iraq could eventually end up like Libya, said Liam Denning in The Wall Street Journal. In that kind of civil war-torn environment, developing Iraq's oil reserves would be a tall order.
Look what happened to Libyan production. It has oscillated between zero and 1.75mbpd. Before the war it was supposed to reach 2mbpd by 2015. It'll be lucky to get there by 2019.
So the danger in the next few years is higher oil prices dampening global growth further. World output growth has been "sluggish" ever since oil exceeded $100 a barrel, as Capital Economics pointed out, "and activity has tended to slow sharply once the oil price tops $120".
That looks like the "danger point" for a world economy still struggling to overcome the hangover from the global financial crisis.
Andrew is the editor of MoneyWeek magazine. He grew up in Vienna and studied at the University of St Andrews, where he gained a first-class MA in geography & international relations.
After graduating he began to contribute to the foreign page of The Week and soon afterwards joined MoneyWeek at its inception in October 2000. He helped Merryn Somerset Webb establish it as Britain’s best-selling financial magazine, contributing to every section of the publication and specialising in macroeconomics and stockmarkets, before going part-time.
His freelance projects have included a 2009 relaunch of The Pharma Letter, where he covered corporate news and political developments in the German pharmaceuticals market for two years, and a multiyear stint as deputy editor of the Barclays account at Redwood, a marketing agency.
Andrew has been editing MoneyWeek since 2018, and continues to specialise in investment and news in German-speaking countries owing to his fluent command of the language.
The fallout from the war on landlords
Investors fleeing the market and the rise in rents are affecting us all.
By Charlie Ellingworth Published
Eight small-cap trusts to bet on
Funds investing in market minnows are out of favour, but the cycle will turn. Here are the best bets.
By Max King Published